Labcorp EBITDA 2010-2024 | LH

Labcorp EBITDA for the quarter ending September 30, 2024 was $0.418B, a 1.14% increase year-over-year.

  • Labcorp 2023 EBITDA was 1.303B, a 33.99% decline from 2022.
  • Labcorp 2022 EBITDA was 1.974B, a 45.56% decline from 2021.
  • Labcorp 2021 EBITDA was 3.626B, a 2.64% increase from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Labcorp EBITDA 2010-2024 | LH

  • Labcorp 2023 EBITDA was 1.303B, a 33.99% decline from 2022.
  • Labcorp 2022 EBITDA was 1.974B, a 45.56% decline from 2021.
  • Labcorp 2021 EBITDA was 3.626B, a 2.64% increase from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
McKesson (MCK)$78.2B
Becton Dickinson (BDX)$64.4B
Cardinal Health (CAH)$28.6B
West Pharmaceutical Services (WST)$22B
Cooper (COO)$19.7B
Align Technology (ALGN)$16.6B
Henry Schein (HSIC)$9.3B
Merit Medical Systems (MMSI)$6.1B
DENTSPLY SIRONA (XRAY)$3.8B
CONMED (CNMD)$2.2B
Patterson (PDCO)$1.8B
STAAR Surgical (STAA)$1.3B
Lifevantage (LFVN)$170M
Pro-Dex (PDEX)$147M